Thema: US67022C3043
NCNA, US67022C3043
stock-1863880_1920.jpg - Foto: THN
NuCana stock: Edison lists ProTide oncology focus
NuCana stock remains a clinical-stage oncology story centered on its ProTide technology. Edison also tracks the company in the healthcare sector.
ad-hoc-news.de, heute 00:46 Uhr
NCNA, US67022C3043
NuCana won a European patent: what it means for NuCana stock ...
NuCana won a European patent on September 30, 2026. NuCana stock now has more than 85 issued patents and funding planned into 2029.
ad-hoc-news.de, 16.10.26 01:39 Uhr
NCNA, US67022C3043
NuCana stock gained 2.83 percent on October 6 as patent ...
NuCana stock was last at USD 1.09 on October 6, 2026, after a 2.83 percent session gain. A European patent expands NUC-7738 protection beyond 85 issued patents.
ad-hoc-news.de, 07.10.26 02:05 Uhr
